Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus-Reference-Cited by-同舟云学术

Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus

Published:2004-09-02 Issue:21 Volume:11 Page:1559-1567
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Wang XY,Martiniello-Wilks R,Shaw JM,Ho T,Coulston N,Cooke-Yarborough C,Molloy PL,Cameron F,Moghaddam M,Lockett TJ,Webster LK,Smith IK,Both GW,Russell PJ

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3302308.pdf

Reference42 articles.

1. Landis SH, Murray T, Bolden S, Wingo PA . Cancer statistics, 1998. CA Cancer. J Clin 1998; 48: 6–29.

2. Denis L, Murphy GP . Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer. Cancer (Phila.) 1993; 72: 3888–3895.

3. Eastham JA et al. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Hum Gene Ther 1996; 7: 515–523.

4. Martiniello R et al. In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-prodrug systems delivered by identical adenovirus vectors. Hum Gene Ther 1998; 9: 1617–1626.

5. Hermann JR et al. In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial. Hum Gene Ther 1999; 10: 1239–1249.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing cytochrome P450 enzymes for use in cancer gene therapy;Frontiers in Bioengineering and Biotechnology;2024-05-24

2. Microbial Enzymes used in Prodrug Activation for Cancer Therapy: Insights and Future Perspectives;Current Protein & Peptide Science;2021-12-07

3. High-Efficiency Lentiviral Gene Modification of Primary Murine Bone-Marrow Mesenchymal Stem Cells;Methods in Molecular Biology;2019

4. Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors;Current Pharmaceutical Design;2018-02-16

5. Antitumor effects of a dual-specific lentiviral vector carrying the Escherichia coli purine nucleoside phosphorylase gene;International Journal of Oncology;2017-04-04